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Abstract 
Having access to suitably stable, functional recombinant protein samples underpins diverse 
academic and industrial research efforts to understand the workings of the cell in health and 
disease. Synthesising a protein in recombinant host cells typically allows the isolation of the 
pure protein in quantities much higher than those found in the protein's native source. Yeast 
is a popular host as it is a eukaryote with similar synthetic machinery to the native human 
source cells of many proteins of interest, whilst also being quick, easy and cheap to grow and 
process. Even in these cells the production of some proteins can be plagued by low functional 
yields. We have identified molecular mechanisms and culture parameters underpinning high 
yields and have consolidated our findings to engineer improved yeast cell factories. In this 
chapter we provide an overview of the opportunities available to improve yeast as a host 
system for recombinant protein production. 
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1. Introduction 
The development of recombinant protein production hosts that can be used to produce a wide 
range of targets is a key area of research (1). This is particularly true for the production of 
membrane proteins, which are high value targets in the drug discovery pipeline, and which 
cannot yet be produced in high yields in a predictable manner (2, 3). Yeast species, especially 
Pichia pastoris and Saccharomyces cerevisiae (2, 4-6) have already been identified as one of 
the most important components of a matrix of protein production hosts (7), and have 
contributed a substantial number of functional (8) recombinant eukaryotic membrane proteins 
in very high yields (e.g. (9)) thus enabling high resolution structure determination (10-13).  
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Yeasts are well-characterised organisms and can be cultured very cheaply and easily in large 
quantities. They are also straightforward to manipulate genetically: publicly-available 
sequences are available for both P. pastoris (14) and S. cerevisiae (15). As yeasts are 
eukaryotes, they have protein-processing and post-translational modification mechanisms 
related to those found in mammalian cells. However, they contain ergosterol rather than 
cholesterol in their membranes and recombinant proteins produced using yeast may be 
decorated with high-mannose type sugars, which are not native to mammalian cells (2). 
Fortunately these problems have been overcome, in part, through strain engineering (16, 17). 
Despite these potential limitations, recombinant pharmaceuticals including insulin (18) and 
several vaccines (e.g. (19)) have all been produced in yeasts for commercial use, 
demonstrating their importance to the pharmaceutical industry.  In order to optimise their 
productivity, two complimentary approaches have been taken: engineering the yeast strain 
and modifying the culture or ‘bioprocess’ conditions. Both are discussed in this chapter and 
are exemplified by studies on S. cerevisiae. 
 
2. Host cell engineering to increase recombinant protein yields 
Strategies to increase the recombinant protein productivity of host cells have been examined 
in both prokaryotic and eukaryotic cells. For example, a strain of Escherichia coli with high 
cardiolipin content (14% compared with 3% in wild-type strains) has been found to produce 
increased yields of some proteins (20, 21). Lactococcus lactis has also been evolved to 
generate strains with modest improvements in their yield properties (22). In both cases 
mutations in the promoter system, and not in any in vivo cellular components of the 
translation or folding machinery, were found to have slowed the protein synthesis rate, 
presumably allowing the newly-synthesised protein to be accommodated into the 
endoplasmic reticulum with a minimum of inclusion body formation and cell death.  
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We and others have used a more systematic approach (23-25) to optimise a host cell for 
recombinant protein production, with the specific goal of understanding the molecular 
barriers to achieving high yields. We therefore looked at the global host cell response to 
producing a membrane protein in S. cerevisiae (23). Using transcriptome arrays, we 
examined two different growth conditions that both led to relatively low protein yields 
(compared with normal conditions) and looked for changes in mRNAs that occurred in the 
same direction in both sets. This highlighted a set of genes, which was validated against those 
identified when comparing the single high-yielding growth condition with normal conditions. 
Genes that were down-regulated under low-yielding conditions were up-regulated under 
high-yielding conditions and vice versa (26). This allowed us to identify genes that 
influenced the yield per cell (27): three are known components of the transcriptional SAGA 
(GCN5 and SPT3) and mediator (SRB5) complexes, whilst a fourth, BMS1, is involved in 
ribosome biogenesis (26). Interestingly, there was an increase in BMS1 transcript number 
compared to wild-type in all our high-yielding host strains. In particular, we were able to tune 
the expression of BMS1 to maximise yields (26).  
 
Work such as this has highlighted other relevant pathways for further study. For example in 
producing a recombinant membrane protein, there may be a benefit in altering the membrane 
lipid content in the host cell (25), as has been seen previously for E. coli strains (20, 21). 
Opi1 protein acts as a transcriptional suppressor, affecting the synthesis of phospholipids 
(28). An opi1∆ strain therefore contains increased phospholipid concentrations compared 
with wild-type strains (29). A study of strains with altered lipid composition in our own 
laboratory (e.g. opi1∆, bio2∆ and erg6∆) revealed that opi1∆ yielded 8 times more protein 
than the corresponding wild-type strain (unpublished). Similar studies in P. pastoris on the 
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global response to producing a recombinant protein (e.g. (30)) should soon lead to similar 
advances. 
 
3. Optimising culture conditions to increase recombinant protein yields 
Although the potential returns are high, engineering a host organism to increase recombinant 
protein yields can be expensive and time-consuming, especially if strategies are based on 
transcriptome analysis. An alternative, complimentary and potentially cheaper route is to 
optimise the experimental culture conditions, ideally using a statistical design of experiments 
approach (see Chapter 11). The development of growth media for mammalian cell culture 
has led the way in this area. For example, medium composition has been key to maintaining 
viable, high density cultures to obtain increased monoclonal antibody titres (31) or to be able 
to use chemically-defined serum-free medium (32, 33).  
 
Variations in the composition of the culture medium, its pH, its temperature, the availability 
of dissolved oxygen and the details of the induction regime (e.g. concentration of inducer, as 
well as the point and duration of induction) may all lead to improvements in the productivity 
of yeast cultures. For example, the yield of active G protein-coupled receptors (GPCRs) 
produced in P. pastoris was increased in over half the cases when the growth medium was 
supplemented with 2.5% dimethyl sulfoxide (DMSO; 16 out of 20) or 0.04 mg mL-1 L-
histidine (12 out of 20) (34). However, in another study, the human tetraspanin protein, 
CD81, was produced and purified from P. pastoris (35), but supplementation with 2.5% 
DMSO did not increase yields (unpublished). Often, however, the induction regime in P. 
pastoris has a much greater effect on yield than the growth conditions (36).  
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For cultivating S. cerevisiae, the most commonly-used media formulations in our laboratory 
are CBS (devised by the Centralbureau voor Schimmelcultures, the Netherlands; (37)) and 
those based on YNB (Yeast Nitrogen Base; (38)). YNB-based media are simpler to make 
than CBS, and originate from the work of Burkholder and Wickermann who used alterations 
in growth media to discriminate between yeast strains (39-41). For use with typical 
auxotrophic laboratory strains, both formulations require additional supplementation with an 
amino acid mixture, adenine and uracil (e.g. complete supplement mixture or CSM), as well 
as a carbon source (see Notes 1 and 2). Growth to medium cell densities (OD600 < 50) is 
possible in 2 × CBS medium supplemented with 20 or 50 g L-1 glucose as the carbon source 
(42, 43), while growth in a YNB-based medium typically yields less biomass and thus less 
recombinant protein. The use of alternative carbon sources, such as ethanol, has also been a 
route to increased protein yields (44). Overall, CBS medium supports a higher growth rate 
than YNB-based medium, but is much more labour intensive to prepare (23). 
 
[Insert Table 1 here] 
 
It has become clear in our own studies that YNB-based media are not ideal for protein 
production in S. cerevisiae (25). In order to combine the simplicity of the YNB-based 
formulation (see Note 1) with the improved performance of CBS medium (see Note 2), we 
have undertaken further optimisation studies. For example, since the membranes of the 
endoplasmic reticulum have a high content of phosphoinositol lipids, we examined the effect 
of supplementing a YNB-based medium with myo-inositol to the levels found in CBS (Table 
1) on recombinant membrane protein yield. Initial data suggesting that yields were improved 
(unpublished) are consistent with our previous observations for the opi1∆ strain, above, as 
well as literature reports suggesting that myo-inositol is essential for relieving some cellular 
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stresses caused by recombinant membrane protein production (45). Furthermore, 
supplementation with myo-inositol (as well as biotin; Table 1) was found to increase growth 
rates to values typical of CBS medium. Adding both myo-inositol and biotin also increased 
the growth rate, but less dramatically (Figure 1). Addition of cobalt was found to decrease 
the growth rate even in the presence of myo-inositol and biotin, although in the presence of 
copper this decrease did not occur. Observations such as these could be followed up using a 
statistical design (46-48) to minimise the number of experiments required to examine all 
possible combinations of these medium components; especially as metal ion requirements for 
S. cerevisiae are often strain specific (49) (see Chapter 11). 
 
[Insert Figure 1 here] 
 
The beneficial effect of adding myo-inositol to YNB-based media on recombinant membrane 
protein yield may indicate that different medium components could be fine-tuned to relieve 
the stresses induced during recombinant soluble protein expression (50). For example 
induction of the unfolded protein response (51) might require a different balance of nutrient 
components. Adding only the required nutrients at just the right concentration for maximum 
productivity should enable this to be achieved in the most cost- and time-effective manner. 
 
4. Conclusions 
YNB-based media are quick and easy to make, but do not support optimal recombinant 
protein yields. Supplementing the formulation with additional myo-inositol and biotin may 
overcome these limitations. This is especially true for recombinant membrane proteins. 
 
5. Notes 
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1. A YNB-based medium for a strain with a given auxotrophy is composed of 1.7 g L-1 
YNB (without ammonium sulphate and amino acids, BIO101 #4027-012), 5 g L-1 
ammonium sulphate and CSM minus the relevant component, as directed by the 
manufacturer (BIO101 #4510-333). Glucose is autoclaved separately as a 20% stock 
solution and added to a final concentration of 2%. If the glucose is autoclaved together 
with the ammonium sulphate and YNB, the solution will have a yellowish appearance. 
At a final OD600 <15 this will not affect growth, but it is quite probable that nutrient 
limitation events will occur when growing to higher densities (using e.g. 5% glucose), 
due to glucose-induced reactions during autoclaving of the nutrients together. It is 
generally considered that the maximum glucose concentration that a YNB-based 
medium will support is 5%; at higher glucose concentrations, for example in a fed-
batch culture, additional nutrients should be provided. 
2. 2 × CBS medium is composed of 10 g L-1 ammonium sulphate, 6 g L-1 potassium 
dihydrogen phosphate, 1 g L-1 magnesium sulphate heptahydrate plus twice the amount 
of CSM minus the relevant component directed (BIO101 #4510-333). Glucose is 
autoclaved separately as a 20% stock solution and added to a final concentration of 2%. 
Finally, 2 mL L-1 each of trace element solution and vitamin stock solution are added. 1 
L trace element solution is composed of the following: 15 g EDTA, 4.5 g ZnSO4·7H20, 
1 g MnCl2·4H2O, 0.3 g CoCl2·6H2O, 0.3 g CuSO4·5H2O, 0.4 g Na2MoO4·2H2O, 4.5 g 
CaCl2·2H2O, 3g FeSO4·7H2O, 1g H3BO3 and 0.1 g KI. The pH is maintained at 6.0 with 
1 M NaOH throughout the addition and finally adjusted to pH 4 with 1 M HCl prior to 
autoclave sterilisation and storage at 4°C in the dark. 1 L vitamin solution is composed 
of the following: 0.05 g biotin, 1 g calcium D-panthothenate, 1 g nicotinic acid, 25 g 
myo-inositol, 1 g thiamine hydrochloride, 1 g pyridoxol hydrochloride and 0.2 g D-
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amino benzoic acid. The pH is maintained at 6.5 with 1 M HCl. The vitamin solution is 
filter-sterilised and stored as 20 mL aliquots at 4°C. 
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Figure legend 
 
Figure 1: Specific growth rates for S. cerevisiae strain BY4741 producing recombinant Fps1. 
The specific growth rate (µ; h-1) was computed using the amount of base added in two 
adjacent 20 min segments in the 2-14 g L-1 residual glucose range (23). The average dry 
weight after consumption of the carbon source (at 55 h) was 0.17g biomass (g glucose)-1. 
This value increased by 0.04 g g-1 in the presence of myo-inositol and biotin. Media additions 
to YNB are as follows: myo-inositol (open squares); biotin (open diamonds); myo-inositol/ 
biotin/zinc/cobalt (filled squares); myo-inositol/biotin (open triangles); myo-
inositol/biotin/zinc/cobalt/copper (crosses); myo-inositol/ biotin/zinc (open circles). YNB 
alone is shown as a large filled circle. 2 × CBS is shown as a large open circle. Individual dry 
weight values (g g-1) are listed in parenthesis after each condition (n=2; standard deviation < 
0.008 for all data points). 
 
  
18 
 
Table 1: Comparison of selected nutrient components in media based on CBS and YNB 
formulations. 
 
 
Nutrient 
 
CBS 
(mg L-1) 
 
YNB 
(mg L-1) 
 
Factor difference 
(CBS:YNB) 
 
Biotin 0.05 0.002 25 
myo-inositol 25 2 12.5 
Cobalt chloride hexahydrate 0.3 0 ∞ 
Zinc sulphate heptahydrate 4.5 0.4 11.25 
Copper sulphate pentahydrate 0.3 0.062 7.5 
 
S. cerevisiae requires a minimum concentration of Cu2+, Zn2+ and Fe2+ of 15, 200 and 150 µg 
L-1, respectively (49). In YNB-based media these concentrations are typically 16, 91 and 88 
µg L-1, respectively, and in CBS they are 76, 1,023 and 602 µg L-1, respectively. Other metal 
ions not included in the YNB formulation are Co2+ and Ni2+. Cobalt in particular is known to 
have an inhibitory effect on growth (52). Boric acid is present in YNB-based formulations at 
a concentration of 500 µg L-1 (8µM) and is known to increase biomass yields during 
respiratory growth at 150 µM (53). The five nutrients with the largest difference in 
concentration between CBS and YNB media are listed. 
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